P4s display posters at ASHP virtual midyear meeting

This year’s DKICP P4 class was well-represented at the recent American Society of Health Systems Pharmacy (ASHP) Midyear Clinical Meeting and Exhibition, held in a virtual format December 6-10, 2020. Conference attendees can view poster PDFs and audio clips of participants summarizing projects online through March 10, 2021. Authors also were available for real-time video question and answer chats alongside their virtual posters. This year’s DKICP participants and their poster titles included:

• Cody Porter, “Effect of including medications in the 2017 heart failure guidelines on Medicare Part D beneficiary utilization”
• Henry Quach, with co-author Bryce Fukunaga, “2013-2017 Atrial fibrillation deaths and Medicare anticoagulant prescription rates”
• Viky Huang, “Association between influenza vaccination and COVID-19 cases among states”
• Kara Tsuzaki, with co-author Deborah Taira, “Analyzing early adoption of combination product Sacubitril and Valsartan by state in Medicare enrollees”
• Jake Hoctor, with co-authors Raha Hosseini, Nicole Young, Sheri Tokumaru, “Assessing the need to restructure interprofessional education collaborative care and telehealth communication practices in pharmacy school curriculums in response to COVID-19”
• Raha Hosseini, with co-authors Jake Hoctor, Sheri Tokumaru, Nicole Young, “Evaluation of drug removal by plasmapheresis among critically ill patients receiving antiepileptic and antimicrobial agents”
• Kimberly Tran, with co-author Bryce Fukunaga, “Evaluating the impact of pharmacist-specific naloxone law implementation on opioid overdose death rates in the United States”
• Qixin Li, with co-authors Leng Chee Chang, Supakit Wongwiwatthananukit, “Patterns and trends in opioid analgesic-prescribing rates among medical specialties and populations in Hawaiʻi”
• Bruce Meno, with co-authors Tiana E. Ramos, Tiana L. Ramos, Marie Cidera, Bruce Fukunaga, “Promoting the benefits of longevity principles to first-year student pharmacists in Hawaiʻi”
• Brooke Higa, with co-authors Aryn Meguro, Bryce Fukunaga, “Number of national diabetes prevention programs in relation to prediabetes prevalence by state”
• Yan Yee Ho, “Examining how medication adherence relates to patient copayment for antidiabetic medications among Medicare Part D beneficiaries”
• Trisha Nobriga, with co-authors Brooke Higa, Bryce Fukunaga, “Amount of diabetic medications with weight loss benefits in comparison to obesity rates in each state from 2013 to 2017”
• Donald Waddell, with co-author Jarred Prudencio, “Impact of the pharmacist in guideline directed SGLT-2 inhibitor and GLP-1 agonist use in patients with diabetes mellitus and clinical atherosclerotic cardiovascular disease”
• Faye Victoria Diez, “Does pneumococcal vaccination reduce the risk of Alzheimer’s Disease in the U.S.?”
• Tiffany Wong, with co-authors Danh Nguyen, Bryce Fukunaga, “Diabetes mellitus 2020 guidelines: Prescribing trends between Hawaiʻi and the continental United States”
• Kimo Okamoto, with co-authors Katherine Chun, Cynthia Yeh, “Implementation of a pharmacist-led intravenous levothyroxine dosing protocol and standardized operating procedure designed to decrease off-label use and reduce cost”
• Lillian Tran, with co-authors Laura Lum, Trisha Masuda, Kimo Okamoto, ShariAnn Tamaru, “Examination and implementation of an atrial fibrillation safety net workflow transition”
• Ifeanyi Agochukwu, with co-author Deborah Taira, “Regional variation in Ledipasvir/Sofosbuvir use, cost and prescribers of Medicare beneficiaries”
• Habibo Salad, with co-author Bryce Fukunaga, “Comparison of opioid claims and naloxone claims with opioid death rates in 2017 in the United States”
• Tiana Enos-Dano, with co-authors Sean Domingo, Laura Ota, “Implementation of a targeted medication safety best practice: Storage of neuromuscular blocking agents in a hospital setting”
• Brian Petrone, with co-author Deborah Taira, “Examining the variation of glecaprevir/pibrentasvir usage by state among Medicare enrollees”